Source-grounded facts extracted from NRC HEALTH's SEC 8-K filings across all families, newest first. Each cites a verbatim SEC excerpt.
NRC HEALTH reported first quarter ended March 31, 2026 results: revenue $34.8 million, net income $3.2 million, EPS $0.14.
“outcomes driver, helping healthcare organizations turn Human Understanding into measurable, repeatable improvement." First Quarter 2026 Highlights ● Revenue: Total revenue was $34.8 million for the three months ended March 31, 2026, up 4% from the prior year ● Net Income : GAAP net income was $3.2 million, representing 9% of revenue, and Adjusted Net Income* was”
NRC HEALTH: Adopted amended and restated Bylaws declassifying the Board of Directors and making other changes (effective 2026-04-15).
“Also on April 15, 2026, the Company’s Board of Directors (the “Board”) adopted and approved, effective April 15, 2026, amended and restated Bylaws of the Company (as amended and restated, the “A&R Bylaws”).”
NRC HEALTH: Changed corporate name to NRC Health pursuant to amendment to certificate of incorporation (effective 2026-04-15).
“On April 15, 2026, National Research Corporation (the “Company”) changed its corporate name to NRC Health (the “Name Change”) pursuant to an amendment to the Company’s certificate of incorporation filed with the Delaware Secretary of State and effective on April 15, 2026 (the “Charter Amendment”).”
Jordan N. Freeman was appointed as Chief Accounting Officer at NRC HEALTH.
“appointed Jordan N. Freeman as the Company’s Chief Accounting Officer.”
Michael D. Hays changed role as principal financial officer at NRC HEALTH.
“designated Michael D. Hays, the Company’s Chief Executive Officer, to serve as the Company’s principal financial officer.”
Trent Green was appointed as Chief Executive Officer at NRC HEALTH.
“the board of directors of National Research Corporation, a Delaware corporation (the “Company”) appointed Trent Green as our Chief Executive Officer and to serve as a director, both effective June 1, 2025.”
Linda Stacy was appointed as Interim Principal Financial Officer at NRC HEALTH.
“the Board appointed Linda Stacy to serve as Interim Principal Financial Officer until March 31, 2025”
Micheal D. Hays changed role as Chairman at NRC HEALTH.
“Micheal D. Hays, the Company’s current Chief Executive Officer, will transition to the role of Chairman”
Trent Green was appointed as Chief Executive Officer at NRC HEALTH.
“the Board appointed Trent Green as the Company’s Chief Executive Officer and to serve as a director, both effective June 1, 2025”
Linda Stacy retired as Secretary, Principal Financial Officer, and Principal Accounting Officer at NRC HEALTH.
“On November 8, 2024, Linda Stacy, Secretary, Principal Financial Officer, and Principal Accounting Officer of National Research Corporation (the “Company”), notified the Company of her decision to retire effective December 31, 2024.”
Helen L. Hrdy was appointed as Chief Operating Officer at NRC HEALTH.
“On October 14, 2024, the Board of Directors of National Research Corporation, a Delaware corporation (the "Company"), appointed Helen L. Hrdy as the Company’s Chief Operating Officer.”
NRC HEALTH shareholders approved An advisory vote to approve the compensation of the Company’s named executive officers as disclosed in the Company’s proxy statement relating to the Annual Meeting at the 2024-05-08 meeting.
“The shareholders approved on an advisory basis the compensation of the Company’s named executive officers as disclosed in the Company’s proxy statement relating to the Annual Meeting. The results of the non-binding, advisory vote were as follows: For Against Abstain Broker Non-Votes Votes Percentage (1) Votes Percentage (1) Votes Percentage (2) Votes Percentage (2) 21,971,558 98.88% 248,724 1.11% 64,095 N/A 582,200 N/A”
NRC HEALTH shareholders approved Ratification of the appointment of KPMG LLP as the Company’s independent registered public accounting firm for 2024 at the 2024-05-08 meeting.
“The shareholders ratified the appointment of KPMG LLP as the Company’s independent registered public accounting firm for 2024. The results of the vote were as follows: For Against Abstain Broker Non-Votes Votes Percentage (1) Votes Percentage (1) Votes Percentage (2) Votes Percentage (2) 22,668,033 99.18% 186,289 0.81% 12,255 N/A 0 N/A”
NRC HEALTH shareholders approved Election of two directors, Michael D. Hays and John N. Nunnelly, to the Board for a three-year term to expire at the Company’s 2027 annual meeting of shareholders at the 2024-05-08 meeting.
“The shareholders elected Michael D. Hays and John N. Nunnelly as directors for three-year terms to expire at the Company’s 2027 annual meeting of shareholders. The results of the vote were as follows: For Against Abstain Broker Non-Votes Name Votes Percentage (1) Votes Percentage (1) Votes Percentage (2) Votes Percentage (2) Michael D. Hays 21,614,892 97.12% 640,441 2.87% 29,044 N/A 582,200 N/A John N. Nunnelly 20,297,568 91.20% 1,957,765 8.79% 29,044 N/A 582,200 N/A”
Linda Stacy was appointed as Principal Financial Officer at NRC HEALTH.
“On May 7, 2024, the Company’s Board of Directors appointed Linda Stacy as the Company’s Principal Financial Officer.”
Facts are extracted by an LLM and gated to those whose source quote is present verbatim in the filing text. Coverage is best-effort while backfill and monitoring mature; this is not yet a full-market index. See methodology.